Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Environmental factors and their regulation of immunity in multiple sclerosis.
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
High spatial and angular resolution diffusion-weighted imaging reveals forniceal damage related to memory impairment.
Multiple sclerosis.
Efficacy and safety of cutting balloons for the treatment of obstructive lesions in the internal jugular veins.
Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
Determinants of ligand binding and catalytic activity in the myelin enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase.
Acute Disseminated Encephalomyelitis Associated With Acute Toxoplasma gondii Infection.
Progressive Disorganization of Paranodal Junctions and Compact Myelin Due to Loss of DCC Expression by Oligodendrocytes.
Is the IL-10 Promoter Polymorphism at Position -592 Associated with Immune System-Related Diseases?
Spasticity in patients with multiple sclerosis - clinical characteristics, treatment and quality of life.
Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen.
Only low frequency event-related EEG activity is compromised in multiple sclerosis: insights from an independent component clustering analysis.
VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.
FDA Approves New Drug to Treat Psoriasis
Switch-associated protein 70 antibodies in multiple sclerosis: relationship between increased serum levels and clinical relapse.
Concepts for regulation of axon integrity by enwrapping glia.
Positive Effect on Multiple Sclerosis With Treatment of Metabolic Syndrome.
Beneficial effects of Rituximab in patients with anti-MAG (myelin-associated glycoprotein) neuropathy: case reports.
Effects of different focus of attention rehabilitative training on gait performance in Multiple Sclerosis patients.
Gene Therapy of Multiple Sclerosis Using Interferon β -Secreting Human Bone Marrow Mesenchymal Stem Cells.
MRI unsampling using feature-based non-local means approach.
Multiple sclerosis: T-cell resistance to regulation in RRMS linked to IL-6 pathway.
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
Myelin Basic Protein and a Multiple Sclerosis-related MBP-peptide Bind to Oligonucleotides.
Pages
« first
‹ previous
…
266
267
268
269
270
271
272
273
274
…
next ›
last »